India’s drug industry saved the world once. Can it do it again?

The phone rang just before midnight.  It was early February in 2001 in Mumbai, and Yusuf Hamied, a seasoned chemist at the Indian multinational pharma company Cipla, was at a dinner party. He picked up the phone anyway. A New York Times reporter was on the line, calling to check a rumor: Was Hamied really offering HIV meds for $1 a day? This story is part of the 2025 Future Perfect 25 Every year, the Future Perfect team curates the undersung activists, organizers, and thinkers who are making the world a better place. This year’s honorees are all keeping progress on global health